Biotech · Private company
Bond Avillion 2 Development LP
Track this companyFree. Adds Bond Avillion 2 Development LP to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs14From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline14
- Albuterol sulfate metered dose inhaler / AS MDI 180 μgPhase 3 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- Albuterol sulfate metered-dose inhaler 180 μgPhase 3 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- AS MDIPhase 3 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- BDA MDIPhase 3 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- Budesonide metered dose inhaler / BD MDI 160 µgPhase 3 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- Budesonide/albuterol sulfate metered dose inhaler / BDA MDI 160/180 μg (high dose)Phase 3 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- Budesonide/albuterol sulfate metered dose inhaler / BDA MDI 80/180 μg (low dose)Phase 3 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- Budesonide/albuterol sulfate metered-dose inhaler 160/180 μgPhase 3 · Exercise Induced BronchospasmClinicalTrials.gov · fetched Nov 12, 2026
- Budesonide/albuterol sulfate metered-dose inhaler 160/180 μgPhase 3 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- Budesonide/albuterol sulfate metered-dose inhaler 80/180 μgPhase 3 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- M1095 (Sonelokimab)Phase 2 · PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- SecukinumabPhase 2 · PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- BDA MDI (PT027) 160/180 μgPhase 1 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- Pulmicort Respules 0.5 MG/ML Inhalation SuspensionPhase 1 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- A Comparison of PT027 vs PT007 Used as Needed in Participants With AsthmaPHASE3 · COMPLETED · started Sep 2, 2022ClinicalTrials.gov NCT05505734 · fetched Nov 12, 2026
- To Compare the Pharmacokinetics of Budesonide Delivered by BDA MDI to Budesonide Delivered by Pulmicort Respules in Children With Asthma Aged 4 to 8 Years.PHASE1 · COMPLETED · started May 6, 2021ClinicalTrials.gov NCT04848662 · fetched Nov 12, 2026
- A Study to Assess the Efficacy of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) on Exercise-induced Bronchoconstriction in Adults and Adolescents With AsthmaPHASE3 · COMPLETED · started Jan 15, 2020ClinicalTrials.gov NCT04234464 · fetched Nov 12, 2026
- A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered Dose Inhaler (BDA MDI/PT027) Used 4 Times Daily in Adults and Children 4 Years of Age or Older With AsthmaPHASE3 · COMPLETED · started Mar 20, 2019ClinicalTrials.gov NCT03847896 · fetched Nov 12, 2026
- A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adults and Children 4 Years of Age or Older With AsthmaPHASE3 · COMPLETED · started Dec 13, 2018ClinicalTrials.gov NCT03769090 · fetched Nov 12, 2026
- A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe PsoriasisPHASE2 · COMPLETED · started Jul 31, 2018ClinicalTrials.gov NCT03384745 · fetched Nov 12, 2026